Belpointe Asset Management LLC Dexcom Inc Transaction History

Belpointe Asset Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$114.22 - $140.1 $613,475 - $752,477	5,371 New	5,371 $744,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $174,216 - $202,888	-1,549 Reduced 47.04%	1,744 $224,000
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $48,568 - $57,403	467 Added 16.53%	3,293 $382,000
Q4 2022 Feb 08, 2023	BUY	$84.98 - $122.67 $6,543 - $9,445	77 Added 2.8%	2,826 $320,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $11,528 - $14,221	-151 Reduced 5.21%	2,749 $222,000
Q2 2022 Aug 02, 2022	BUY	$67.99 - $132.89 $149,238 - $291,693	2,195 Added 311.35%	2,900 $216,000
Q1 2022 Apr 28, 2022	BUY	$94.08 - $130.2 $35,656 - $49,345	379 Added 116.26%	705 $361,000
Q4 2021 Feb 15, 2022	SELL	$129.87 - $162.82 $1,428 - $1,791	-11 Reduced 3.26%	326 $176,000
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $13,552 - $18,183	-127 Reduced 27.37%	337 $184,000
Q2 2021 Aug 09, 2021	BUY	$80.99 - $107.93 $37,579 - $50,079	464 New	464 $198,000
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $95,510 - $112,950	-1,000 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$62.68 - $105.34 $62,680 - $105,340	1,000 New	1,000 $406,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.